Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by ICON plc

< Previous 1 2 Next >
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
From ICON plc
Via Business Wire
Tickers ICLR
ICON Issues Financial Guidance for Full Year 2024
From ICON plc
Via Business Wire
Tickers ICLR
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
From ICON plc
Via Business Wire
Tickers ICLR
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Third Quarter 2023 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON Secures Upgraded Credit Rating from S&P Global Ratings
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
From ICON plc
Via Business Wire
Tickers ICLR
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the Baird Global Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Second Quarter 2023 Results
From ICON plc
Via Business Wire
Tickers ICLR
First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Second Quarter 2023 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Set to Join Russell 3000® Index
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Attend Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON releases its 2022 ICON Cares ESG Report
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports First Quarter 2023 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules First Quarter 2023 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Fourth Quarter and Full Year 2022 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Issues Financial Guidance for Full Year 2023
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the 41st Annual J.P. Morgan Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
From ICON plc
Via Business Wire
Tickers ICLR
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.